Latest Us Market News

SomnoMed reports a strong start to FY26 with 13.5% revenue growth and confirms the Clayton Sleep Institute as the first US site for its pivotal Rest Assure clinical study, backed by FDA protocol agreement.

Jumbo Interactive has completed its strategic entry into the US prize draw market by acquiring Dream Giveaway for A$55.4 million, aiming to leverage its digital expertise to fuel growth in a large, underpenetrated market.

James Bay Minerals reports promising high-grade gold-silver drill results at its Independence Gold Project in Nevada and announces a strategic acquisition of the Shafter Silver Project in Texas, backed by a $30 million capital raise.

Tungsten Mining NL reports strong progress on its Mt Mulgine Project, leveraging soaring tungsten prices and a new gold resource estimate to drive development. The company also raises $9.5 million and initiates a US OTCQB listing process.

HyTerra Ltd has successfully completed drilling and appraisal operations in Kansas, revealing elevated hydrogen and helium concentrations that reinforce the potential of its Nemaha Project. The company is advancing its US market presence with an OTCQB listing and strategic advisory appointments.

Smart Parking Limited reports a record FY25 with revenues up 42% to $77.2 million, driven by organic growth and strategic acquisitions including Peak Parking in the US. The company targets 3,000 managed sites by 2028, leveraging proprietary AI technology across multiple international markets.

Orthocell has appointed MontsMed as the exclusive distributor for its nerve repair product Remplir™ in Hong Kong, marking a significant step in its Asian commercialisation strategy. This move opens access to the vast Guangdong-Hong Kong-Macao Greater Bay Area, complementing existing operations in Singapore and planned expansion in Thailand.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.

Hydrix Limited reports a robust quarter with $3.35 million in sales, a 7% revenue increase, and a strong international client base, while advancing US market ventures.

dorsaVi reports breakthrough RRAM sensor performance and secures a major US physical therapy deal, backed by a $5 million capital raise and new leadership appointments.

The Calmer Co. International Limited has delivered its strongest quarter yet, with revenue surging 26% to $2.4 million and operating cash outflows dropping to a historic low. Strategic growth across retail, e-commerce, and B2B channels underpins its confident path to breakeven.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.